December 04, 2019
2 min watch
Save

VIDEO: Oral eplerenone successfully treats central serous chorioretinopathy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEPTUNE, N.J. – A 58-year-old man with distorted vision was diagnosed with central serous chorioretinopathy and was successfully treated with oral eplerenone, 25 mg twice a day, according to Yuyeng Lor, OD, MPH, here at a New Jersey Academy of Optometry continuing education event.

This mineralocorticoid receptor agonist acts as a diuretic, Lor said, and at the patient’s 6-month follow-up the subretinal fluid had resolved, and his vision returned to 20/20.

The NJAO provided a grant for Lor to present her research at the American Academy of Optometry meeting.

Disclosure: Lor reports no relevant financial disclosures.